Stigmasterol ameliorates pulmonary hypertension by suppressing the CCL5/CCR5 signaling pathway: Taurocholic acid as a downstream mediator

Biophysical Reports · Elsevier

Аннотация

Publication date: 10 January 2027 Source: European Journal of Pharmacology, Volume 1040 Author(s): Yuan Tang, Yanping Shi, Mengting Wang, Shuyue Cai, Yifang Suo, Xin Lu, Jiawen Wang, Xinyi Lu, Mengli Chen, Haifeng Zhang

Читать у издателя →

Похожие статьи